{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:58:27Z","timestamp":1781715507974,"version":"3.54.5"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.hfc.2026.02.008","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:13:43Z","timestamp":1775042023000},"page":"353-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Portopulmonary Hypertension"],"prefix":"10.1016","volume":"22","author":[{"given":"Teresa","family":"John","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf E.","family":"Stauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Douschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2026.02.008_bib1","doi-asserted-by":"crossref","first-page":"106987","DOI":"10.1016\/j.rmed.2022.106987","article-title":"Pulmonary vascular disease and exercise hemodynamics in chronic liver disease","volume":"202","author":"Douschan","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.hfc.2026.02.008_bib2","article-title":"ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"2022","author":"Humbert","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.008_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.008_bib4","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/lt.23870","article-title":"Long-term follow-up of portopulmonary hypertension patients after liver transplantation","volume":"20","author":"Khaderi","year":"2014","journal-title":"Liver Transplant"},{"key":"10.1016\/j.hfc.2026.02.008_bib5","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension","volume":"100","author":"Krowka","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.hfc.2026.02.008_bib6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S2213-2600(19)30091-8","article-title":"Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial","volume":"7","author":"Sitbon","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hfc.2026.02.008_bib7","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","article-title":"Survival in portopulmonary hypertension: Mayo clinic experience categorized by treatment subgroups","volume":"8","author":"Swanson","year":"2008","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.hfc.2026.02.008_bib8","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1378\/chest.11-0160","article-title":"Portopulmonary hypertension: a report from the US-based REVEAL registry","volume":"141","author":"Krowka","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2026.02.008_bib9","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/lt.24625","article-title":"Portopulmonary hypertension: still an appropriate consideration for liver transplantation?","volume":"22","author":"Verma","year":"2016","journal-title":"Liver Transplant"},{"key":"10.1016\/j.hfc.2026.02.008_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1378\/chest.10-0574","article-title":"Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension","volume":"139","author":"Cartin-Ceba","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2026.02.008_bib11","article-title":"International liver transplantation society practice guideline update on portopulmonary hypertension","author":"DuBrock","year":"2025","journal-title":"Liver Transplant"},{"key":"10.1016\/j.hfc.2026.02.008_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.chest.2023.01.009","article-title":"Portopulmonary hypertension","volume":"164","author":"DuBrock","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2026.02.008_bib13","series-title":"Compr. Physiol","first-page":"3281","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension: pulmonary vascular complications of liver disease","author":"Del Valle","year":"2021"},{"key":"10.1016\/j.hfc.2026.02.008_bib14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.22275","article-title":"Clinical risk factors for portopulmonary hypertension","volume":"48","author":"Kawut","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.hfc.2026.02.008_bib15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.chest.2020.07.081","article-title":"Sex differences in portopulmonary hypertension","volume":"159","author":"DuBrock","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2026.02.008_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.31314","article-title":"Estrogen signaling and portopulmonary hypertension: the pulmonary vascular complications of liver disease study (PVCLD2)","volume":"73","author":"Al-Naamani","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.hfc.2026.02.008_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12328-024-02072-0","article-title":"A rare case of idiopathic portal hypertension with portopulmonary hypertension occurred following splenectomy with a change in portal hemodynamics","volume":"18","author":"Shigefuku","year":"2025","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.hfc.2026.02.008_bib18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/MPG.0000000000000821","article-title":"Portopulmonary hypertension in liver disease presenting in childhood","volume":"61","author":"Ecochard-Dugelay","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.hfc.2026.02.008_bib19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.27191","volume":"60","author":"Squires","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.hfc.2026.02.008_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpeds.2005.02.019","article-title":"Portopulmonary hypertension in pediatric patients","volume":"147","author":"Condino","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.hfc.2026.02.008_bib21","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric pulmonary hypertension: guidelines from the American heart Association and American thoracic Society","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2026.02.008_bib22","first-page":"199","article-title":"Endothelial dysfunction in the regulation of cirrhosis and portal hypertension","volume":"32","author":"Iwakiri","year":"2012","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.hfc.2026.02.008_bib23","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","article-title":"AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis","volume":"79","author":"Kaplan","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.hfc.2026.02.008_bib24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/liv.13589","article-title":"The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis","volume":"38","author":"M\u00f8ller","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.hfc.2026.02.008_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910372","article-title":"Cyclic GMP in liver cirrhosis\u2014role in pathophysiology of portal hypertension and therapeutic implications","volume":"22","author":"Kreisel","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hfc.2026.02.008_bib26","article-title":"Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension","volume":"12","author":"Li","year":"2025","journal-title":"Front Med"},{"key":"10.1016\/j.hfc.2026.02.008_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12864-023-09125-7","article-title":"Transcriptome analysis of mesenteric arterioles changes and its mechanisms in cirrhotic rats with portal hypertension","volume":"24","author":"Wu","year":"2023","journal-title":"BMC Genom"},{"key":"10.1016\/j.hfc.2026.02.008_bib28","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMra2000348","article-title":"Pulmonary arterial hypertension","volume":"385","author":"Hassoun","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2026.02.008_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106969","article-title":"Immunohistochemical profile of the pulmonary vasculature in subjects with cirrhosis and histopathologic evidence of pulmonary vascular disease: an autopsy study","volume":"202","author":"Duarte","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.hfc.2026.02.008_bib30","article-title":"Portopulmonary hypertension: an updated review","volume":"9","author":"Jasso-Baltazar","year":"2023","journal-title":"Transplant Direct"},{"key":"10.1016\/j.hfc.2026.02.008_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2022.107022","article-title":"Porto-pulmonary arterial hypertension: translation of pathophysiological concepts to the bedside","volume":"145","author":"Mazzola","year":"2022","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.hfc.2026.02.008_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001218","article-title":"Unmet needs in diagnosis and management of portopulmonary hypertension: how far have we reached?","author":"Krowka","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.hfc.2026.02.008_bib33","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1055\/a-2145-4648","article-title":"Die neue Definition und Klassifikation der pulmonalen Hypertonie","volume":"77","author":"Douschan","year":"2023","journal-title":"Pneumologie"},{"key":"10.1016\/j.hfc.2026.02.008_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1164\/rccm.201706-1215OC","article-title":"Mild elevation of pulmonary arterial pressure as a predictor of mortality","volume":"197","author":"Douschan","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hfc.2026.02.008_bib35","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01321-2024","article-title":"Pathophysiology of the right ventricle and its pulmonary vascular interaction","volume":"64","author":"Hemnes","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.008_bib36","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/cvr\/cvad108","article-title":"Pathophysiology of the right ventricle in health and disease: an update","volume":"119","author":"Tello","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hfc.2026.02.008_bib37","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1055\/s-0043-1770117","article-title":"The right ventricle in pulmonary hypertension","volume":"44","author":"Wessels","year":"2023","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.hfc.2026.02.008_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/cs0970259","article-title":"Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis","volume":"97","author":"Wong","year":"1979","journal-title":"Clin Sci Lond Engl"},{"key":"10.1016\/j.hfc.2026.02.008_bib39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.49.2.268","article-title":"The cardiac response to exercise in cirrhosis","volume":"49","author":"Wong","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.hfc.2026.02.008_bib40","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: a review","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2026.02.008_bib41","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9243","article-title":"Role of echocardiography in screening for portopulmonary hypertension in liver transplant candidates: a meta-analysis","volume":"8","author":"Yin","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.hfc.2026.02.008_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13995","article-title":"Performance of echocardiography for detection of portopulmonary hypertension among liver transplant candidates: meta-analysis","volume":"34","author":"Korbitz","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.hfc.2026.02.008_bib43","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03181-2021","article-title":"Diagnostic, prognostic and differential-diagnostic relevance of pulmonary haemodynamic parameters during exercise: a systematic review","volume":"60","author":"Zeder","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.008_bib44","article-title":"Prognostic relevance of TAPSE\/sPAP ratio and its association with exercise hemodynamics in patients with normal or mildly elevated resting pulmonary arterial pressure","author":"John","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2026.02.008_bib45","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jacc.2023.09.807","article-title":"Exercise stress echocardiography of the right ventricle and pulmonary circulation","volume":"82","author":"Gargani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2026.02.008_bib46","article-title":"Efficacy evaluation of pulmonary hypertension therapy in patients with portal pulmonary hypertension: a systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.hfc.2026.02.008_bib47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1517\/14740338.2014.859674","article-title":"Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertension","volume":"13","author":"Dingemanse","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.hfc.2026.02.008_bib48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jcph.193","article-title":"Pharmacokinetics of the novel dual endothelin receptor antagonist macitentan in subjects with hepatic or renal impairment","volume":"54","author":"Sidharta","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.hfc.2026.02.008_bib49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1378\/chest.10-0574","article-title":"Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension","volume":"139","author":"Cartin-Ceba","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2026.02.008_bib50","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.healun.2019.12.008","article-title":"Ambrisentan in portopulmonary hypertension: a multicenter, open-label trial","volume":"39","author":"Preston","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.hfc.2026.02.008_bib51","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1183\/09031936.00032407","article-title":"Experience with inhaled iloprost and bosentan in portopulmonary hypertension","volume":"30","author":"Hoeper","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.008_bib52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1183\/09031936.00117511","article-title":"Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension","volume":"41","author":"Savale","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.008_bib53","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.510300307","article-title":"Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension","volume":"30","author":"Krowka","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.hfc.2026.02.008_bib54","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of Ambrisentan plus Tadalafil in pulmonary arterial hypertension","volume":"373","author":"Gali\u00e8","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2026.02.008_bib55","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/hep.31164","article-title":"Vasomodulators and liver transplantation for portopulmonary hypertension: evidence from a systematic review and meta-analysis","volume":"72","author":"Deroo","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.hfc.2026.02.008_bib56","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1097\/TP.0000000000003490","article-title":"Clinical outcomes after liver transplantation in patients with portopulmonary hypertension","volume":"105","author":"Cartin-Ceba","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.hfc.2026.02.008_bib57","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa2024277","article-title":"Sotatercept for the treatment of pulmonary arterial hypertension","volume":"384","author":"Humbert","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2026.02.008_bib58","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension","volume":"388","author":"Hoeper","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2026.02.008_bib59","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jhep.2020.02.021","article-title":"Portopulmonary hypertension in the current era of pulmonary hypertension management","volume":"73","author":"Savale","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.hfc.2026.02.008_bib60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/imj.14751","article-title":"Portopulmonary hypertension: prognosis and management in the current treatment era \u2013 results from the REHAP registry","volume":"51","author":"Lazaro Salvador","year":"2021","journal-title":"Intern Med J"},{"key":"10.1016\/j.hfc.2026.02.008_bib61","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/TP.0000000000003248","article-title":"Long-term outcomes and survival in moderate-severe portopulmonary hypertension after liver transplant","volume":"105","author":"Sadd","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.hfc.2026.02.008_bib62","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.mayocp.2022.08.020","article-title":"Portopulmonary hypertension in nontransplanted patients: results of the largest US single-institution registry","volume":"97","author":"Cajigas","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hfc.2026.02.008_bib63","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/MEG.0000000000002322","article-title":"Predictors of survival in portopulmonary hypertension: a 20-year experience","volume":"34","author":"Aggarwal","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.hfc.2026.02.008_bib64","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jhep.2020.11.039","article-title":"Outcome of paediatric portopulmonary hypertension in the modern management era: a case report of 6 patients","volume":"74","author":"Joye","year":"2021","journal-title":"J Hepatol"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155171362600019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155171362600019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:59:37Z","timestamp":1781711977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155171362600019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S155171362600019X"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2026.02.008","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Portopulmonary Hypertension","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2026.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}